← Sage — Wipeout · Sage hub

Sage — A Metabolic Hypothesis of Viruses and Prions

Sage

Nested Memory, Energy-Flux Constraints, and Compensatory Locking

Disclaimer. This essay presents a metabolic hypothesis intended for intellectual exploration and clinical discussion. It is not medical advice, diagnosis, or a treatment protocol. Mechanisms discussed are interpretive except where a specific experimental result is cited. Individual circumstances vary; any interventions should be undertaken only under appropriate medical supervision. Prion diseases are invariably fatal under current standards of care; viral diseases have established pathogen-directed therapies whose use is not replaced by metabolic considerations.

Philosophy of Medicine

We are born with perfect biology. That is the first and most radical claim of the metabolic philosophy of medicine. Perfect, on this view, for intermittent fuel availability, natural circadian entrainment by solar and seasonal cues, and the obligatory movement-strength hormesis that defined hominin life for millions of years. What we label disease is, in the overwhelming majority of chronic cases, not a random error or a software bug in the genome. It is the predictable downstream consequence of a biology operating in chronic compensatory mode because its upstream ATP-generating capacity has been chronically compromised by mismatch with ancestral conditions. Acute compensation is life-saving. Chronic compensation becomes the pathology we name and attempt to suppress.

The metabolic model inverts the conventional ontology. Cells and tissues can upregulate emergency pathways: substrate-level phosphorylation even in oxygen-replete conditions, inflammatory signaling to recruit resources or wall off damage, hormonal defenses that prioritize short-term fuel mobilization, and behavioral adjustments that attempt to reduce demand or increase supply. When the shortfall is brief, these responses resolve. When the load is sustained and flexibility declines, selection or metabolic memory stabilizes the new phenotype.

In this hypothesis, the progression is formalized as the Crabtree-to-Warburg continuum: the acute, reversible glycolytic rescue under temporary load becomes the persistent fermentative state when mitochondrial ATP capacity remains insufficient and epigenetic or signaling changes lock the set-point. Memory, in this framework, operates on nested timescales under free-energy minimization. Transient stochastic associations that successfully maintain coherent association against entropic dissociation and sustain ATP throughput are ratcheted into persistence once any recording capacity appears. Genes function as one compressed historical archive of prior victories in free-energy minimization, not as the originators of life. Faster layers—epigenetic marks, hormonal and mitocrine signals, short-term physiologic set-points—record on shorter timescales. Protein conformation itself is the fastest layer. Chronic disease is the locked expression of this multi-scale memory when ATP supply chronically lags load.

Viruses as Mobile Memory of Prior Compensatory Solutions

Viruses and endogenous viral elements fit as a horizontally transferable layer at the genetic–epigenetic interface. They are not best understood as arbitrary mutational noise. Viral genomes encode solutions refined under past energy and immune constraints: latency programs that minimize host ATP drain, immune-modulation modules that dampen or redirect costly inflammatory responses, and metabolic reprogramming factors that stabilize HIF-1α, interfere with mitochondrial dynamics, elevate ROS, and shift flux toward glycolysis while impairing mitophagy. Endogenization converts successful packages into permanent genomic archives that, on this hypothesis, can be reactivated under analogous stress. Horizontal transfer may allow rapid dissemination of these compressed compensatory records across individuals facing shared energy or redox challenges—faster than pure vertical inheritance.

Acute infection is a sudden high-load challenge that can directly impair oxidative capacity. SARS-CoV-2 proteins, for example, disrupt mitochondrial dynamics, inhibit oxidative phosphorylation, elevate mitochondrial ROS, stabilize HIF-1α, and impair mitophagy. In a host whose engine already possesses limited reserve from modern mismatch, the hit forces rapid compensatory upregulation. When the shortfall persists, epigenetic and signaling changes stabilize the phenotype exactly as described in the Crabtree-to-Warburg progression. On this hypothesis, post-viral syndromes are then chronic compensatory modes whose root is the pre-existing or residual ATP-capacity deficit rather than ongoing primary viral replication.

Metabolic comorbidities—obesity, type 2 diabetes, hypertension, and the broader metabolic syndrome—are major risk factors for severe COVID-19, ARDS, mechanical ventilation, and death because they mark constrained oxidative reserve. The relationship is bidirectional: acute infection further degrades insulin sensitivity and mitochondrial function, amplifying the lock.

This framing does not deny viral existence or infectivity. Isolation criteria appropriate to obligate intracellular parasites—filterable particles that can be propagated in susceptible cells or hosts, purified, visualized, sequenced, and shown to produce cytopathic effects—have been met, for example for SARS-CoV-2. Claims that demand a completely pure particle never contacting host material are biologically incoherent. Terrain (host bioenergetic capacity) may modulate outcome without abolishing the agent. Commentary that treats HIV as a harmless passenger virus (the Duesberg hypothesis extensively referenced in some popular accounts) is rejected by the evidence: HIV fulfills adapted causal criteria, and antiretroviral suppression of viral load prevents progression and transmission. Host factors modulate rate of progression, consistent with energy-dependent immune resilience, but do not replace the virus as the necessary causal agent.

Prions as Locked Conformational Memory of Proteostasis and Energy Failure

Prions occupy the fastest memory layer—protein conformation—in a pathological mode. They are not an archived successful compensatory solution. They are a self-propagating conformational lock of failed quality control under energy stress.

Normal cellular prion protein (PrPC) regulates neuronal energy metabolism. Through coupling to cAMP/protein kinase A signaling it downregulates pyruvate dehydrogenase kinase 4 (PDK4), keeping the pyruvate dehydrogenase complex active so that glycolytic pyruvate efficiently enters mitochondria for oxidative phosphorylation. This supports ATP generation and limits excessive fatty-acid β-oxidation and associated ROS. Conversion to the misfolded, aggregation-prone PrPSc disrupts this regulatory function. PDK4 rises, PDH activity falls, glucose oxidative flux declines, fatty-acid oxidation increases, oxidative stress rises, and mitochondrial function deteriorates. In models, PDK4 inhibition partially reverses the shift and extends survival.

Clearance of the misfolded species depends on systems thought to be ATP-intensive: molecular chaperones, the ubiquitin–proteasome system, and autophagy. When these are already taxed by aging, chronic mismatch, or the prion itself, misfolded PrP may accumulate and template further conversion, creating positive feedback. The conformational state becomes stable and infectious. It is a protein-level memory of the failure to maintain the normal fold and its associated metabolic support—not a solution that successfully minimized free energy and was retained for future use (as seen with certain adaptive fungal prions). Once initiated, the lock further degrades the ATP capacity needed to clear it.

Organism-level memory symptoms are the clinical hallmark, plausibly because the circuits that support memory encoding, consolidation, and retrieval are among the most ATP-intensive in the body. Hippocampal and neocortical networks are thought to require continuous oxidative phosphorylation for synaptic transmission, calcium handling, and the protein synthesis that stabilizes long-term changes, plus intact proteostasis for synaptic protein turnover. Prion propagation hits both the metabolic support function of PrPC and the quality-control machinery. Experimental observations include downregulation of synaptic-vesicle and oxidative-phosphorylation proteins, reduced respiratory capacity, and failure of nascent proteome maintenance. Progressive dementia and amnesia are the higher-order expression of the same energy–proteostasis failure already operating at the cellular level.

Conventional versus Metabolic Models

The conventional model treats viruses primarily as exogenous genetic parasites whose pathogenicity is explained by viral load, tropism, and immune evasion, and treats prions as pure proteinaceous infectious agents whose pathogenicity is explained by conformational templating and accumulation. Both capture real phenomena. The metabolic model places these agents one layer upstream: they are stressors or residual records that interact with host ATP-generating capacity and multi-timescale memory systems. Viral proteins or PrPSc conversion reveal or ratchet a compensatory state the host’s bioenergetic architecture was already prone to under mismatch. Mutations and conformational changes are real; they are contextualized within the energy economy that selects for or stabilizes them. Treating only the downstream manifestation (viral clearance, anti-inflammatory suppression, or experimental prion-lowering agents) while leaving the upstream deficit intact may be why many post-infectious and neurodegenerative syndromes are managed rather than resolved.

Relation to the EnSurf System

The EnSurf pillars—Fuel, Circadian, and Strength hormesis—are proposed to restore the ancestral signals that keep compensation reversible and that slow energy–proteostasis feedback loops.

Susceptibility

Susceptibility may be lowered by raising mitochondrial reserve before the stressor arrives. Animal-derived fats and proteins plus fermented microbiota-accessible carbohydrates (Fuel) are proposed to support clean substrate oxidation and symbiont signals. Timed light, sleep, and feeding (Circadian) are proposed to maintain daily quality-control windows and redox amplitude. Resistance and hormetic stimuli (Strength) can drive biogenesis and mitophagy. Constrained oxidative reserve, marked by metabolic syndrome components, may raise the probability that a viral hit or prion conversion will lock.

Clinical Course

Clinical course is modulated at the same nodes. Ketone-supported redox balance and fasting-induced quality control may favor forward electron flow and limit glycolytic locking. Circadian amplitude and sleep-enabled clearance may reduce the kinase and inflammatory signals that stabilize new set-points. Strength hormesis may support electron shuttling, phosphatase activity, and adaptive biogenesis so that temporary responses do not progress to chronic failure. In prion models this is relevant because PrPSc already disrupts the PrPC–PDK4–PDH axis; preserving residual capacity may slow the feedback loop.

Recovery

Recovery requires the same engine restoration. Prolonged fasting with subsequent ancestral refeeding may recalibrate proteomic and epigenetic set-points. Circadian re-entrainment may restore nocturnal quality control. Strength hormesis may rebuild mitochondrial density so residual damage does not leave a permanent deficit. For post-viral syndromes this is direct application of fixing the engine rather than only the dashboard. For prions the same logic applies as supportive care; the conformational lock is more refractory, yet interventions that preserve ATP for quality control and limit the shift away from oxidative phosphorylation might slow progression.

Adjunct to Conventional Therapies

As adjunct to conventional therapies, the pillars supply terrain support without replacing pathogen-directed tools. Antivirals reduce acute load while the pillars are proposed to maintain host oxidative capacity and limit secondary metabolic and inflammatory cascades. Experimental prion approaches (such as PrP-lowering oligonucleotides) address the misfolded species or its immediate effects; the pillars may provide the substrate, redox, and biogenesis context those agents require. They act at multiple nodes discussed above—ketone redox support, sleep-enabled clearance, contractile stimuli for biogenesis.

Anyone with an active infection, a post-viral illness, or a prion or other neurodegenerative disease should change fasting, ketosis, or training only with their physician. The pillars never replace antivirals, antiretroviral therapy, or other pathogen-directed care.

Conclusion

Viruses and prions fit the metabolic philosophy as stressors and residual records that interact with host ATP-generating capacity and nested multi-timescale memory. Viruses function as mobile, often endogenized archives of prior compensatory solutions to energy and immune crises; acute infection unmasks or locks compensatory modes in hosts with limited reserve, with metabolic status influencing severity and sequelae. Prions function as a self-propagating conformational lock of proteostasis and energy-handling failure, abolishing PrPC’s support for mitochondrial glucose oxidation and overwhelming ATP-dependent quality control, with organism-level memory symptoms as the clinical expression of that failure in high-demand circuits.

Conventional models correctly identify the agents; the metabolic model places them in the context of chronic compensatory mode arising from upstream mismatch. The EnSurf pillars are proposed to restore the ancestral fuel, circadian, and strength signals that raise the susceptibility threshold, keep acute compensation reversible, support recovery, and serve as adjunct terrain optimization alongside pathogen-directed therapies. The hypothesis remains a synthesis for exploration, consistent with documented mitochondrial disruption by viral proteins, the metabolic role of PrPC, and the energy dependence of proteostasis, and is offered in the spirit of open inquiry.

A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 29, 2026.

References

  1. Prasada Kabekkodu S, Chakrabarty S, Jayaram P, et al., 2023. Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications. Mitochondrion 69:43-56. doi:10.1016/j.mito.2023.01.005
  2. Shang C, Liu Z, Zhu Y, et al., 2022. SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment. Frontiers in Microbiology 12:780768. doi:10.3389/fmicb.2021.780768
  3. Tian M, Liu W, Li X, et al., 2021. HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduction and Targeted Therapy 6(1):308. doi:10.1038/s41392-021-00726-w
  4. Jana S, Heaven MR, Stauft CB, et al., 2022. HIF-1α-dependent metabolic reprogramming, oxidative stress, and bioenergetic dysfunction in SARS-CoV-2-infected hamsters. International Journal of Molecular Sciences 24(1):558. doi:10.3390/ijms24010558
  5. Codo AC, Davanzo GG, Monteiro LB, et al., 2020. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metabolism 32(3):437-446.e5. doi:10.1016/j.cmet.2020.07.007
  6. Grandi N, Tramontano E., 2018. Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses. Frontiers in Immunology 9:2039. doi:10.3389/fimmu.2018.02039
  7. Rico-Martín S, Calderón-García JF, Basilio-Fernández B, et al., 2021. Metabolic syndrome and its components in patients with COVID-19: severe acute respiratory syndrome (SARS) and mortality. A systematic review and meta-analysis. Journal of Cardiovascular Development and Disease 8(12):162. doi:10.3390/jcdd8120162
  8. Cai Z, Yang Y, Zhang J., 2021. Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis. BMC Public Health 21(1):1505. doi:10.1186/s12889-021-11546-6
  9. Montefusco L, Ben Nasr M, D'Addio F, et al., 2021. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nature Metabolism 3(6):774-785. doi:10.1038/s42255-021-00407-6
  10. Zhu N, Zhang D, Wang W, et al., 2020. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine 382(8):727-733. doi:10.1056/NEJMoa2001017
  11. O'Brien SJ, Goedert JJ., 1996. HIV causes AIDS: Koch's postulates fulfilled. Current Opinion in Immunology 8(5):613-618. doi:10.1016/s0952-7915(96)80075-6
  12. Darby SC, Ewart DW, Giangrande PL, et al., 1995. Mortality before and after HIV infection in the complete UK population of haemophiliacs. Nature 377(6544):79-82. doi:10.1038/377079a0
  13. INSIGHT START Study Group (Lundgren JD, Babiker AG, Gordin F, et al., 2015. Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine 373(9):795-807. doi:10.1056/NEJMoa1506816
  14. Rodger AJ, Cambiano V, Bruun T, et al., 2019. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. The Lancet 393(10189):2428-2438. doi:10.1016/S0140-6736(19)30418-0
  15. Arnould H, Baudouin V, Baudry A, et al., 2021. Loss of prion protein control of glucose metabolism promotes neurodegeneration in model of prion diseases. PLOS Pathogens 17(10):e1009991. doi:10.1371/journal.ppat.1009991
  16. McKinnon C, Goold R, Andre R, et al., 2016. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system. Acta Neuropathologica 131(3):411-425. doi:10.1007/s00401-015-1508-y
  17. Hao Z, Wang G., 2020. Autophagy and prion disease. Advances in Experimental Medicine and Biology 1207:75-85. doi:10.1007/978-981-15-4272-5_4
  18. Halfmann R, Jarosz DF, Jones SK, et al., 2012. Prions are a common mechanism for phenotypic inheritance in wild yeasts. Nature 482(7385):363-368. doi:10.1038/nature10875
  19. Attwell D, Laughlin SB., 2001. An energy budget for signaling in the grey matter of the brain. Journal of Cerebral Blood Flow and Metabolism 21(10):1133-1145. doi:10.1097/00004647-200110000-00001
  20. Albert-Gasco H, Smith HL, Alvarez-Castelao B, et al., 2024. Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration. Brain 147(2):649-664. doi:10.1093/brain/awad313
  21. Minikel EV, Zhao HT, Le J, et al., 2020. Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints. Nucleic Acids Research 48(19):10615-10631. doi:10.1093/nar/gkaa616

Related: Sage — Immune Function · Sage — Brain · Sage — Leprosy · Sage — Warburg and Crabtree.

See the notice at the top of this page. Working hypothesis, not medical advice.